Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epclusa for HCV in Opiate Dependent Patients on Buprenorphine/Naloxone
NCT03235154Phase 4Completed
- Sponsor
- Community Research Initiative of New England
- Start
- Oct 2017
- Primary completion
- Sep 2019
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C (HCV), sponsored by Community Research Initiative of New England. Started Oct 2017; status: completed.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03235154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235154.